Stock IVBT INNOVATION1 BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Innovation1 Biotech Inc.

Equities

IVBT

US39809D2018

Market Closed - OTC Markets
Other stock markets
 14:31:07 19/04/2024 BST 		5-day change 1st Jan Change
0.0008 USD -96.36% Intraday chart for Innovation1 Biotech Inc. -.--% -99.07%
01-17 Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 CI
2023 Innovation1 Biotech Inc. announced that it has received $0.15 million in funding CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023
CI
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding
CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding
CI
Innovation1 Biotech : New Financial Obligation - Form 8-K
PU
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding
CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
CI
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding
CI
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board
CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
CI
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director
CI
Innovation1 Biotech : Material Agreement - Form 8-K
PU
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited
CI
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022
CI
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC
CI
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022
CI
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt
CI
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IVBT Stock
  4. News Innovation1 Biotech Inc.